|
|
||||||||
The Journal of Immunology, Vol 154, Issue 10 4996-5010, Copyright © 1995 by American Association of Immunologists
ARTICLES |
AC Grammer, MC Bergman, Y Miura, K Fujita, LS Davis and PE Lipsky
Immunology Graduate Program, University of Texas Southwestern Medical Center, Dallas 75235, USA.
The possibility that activated B cells might express a ligand for CD40 that was of functional importance for B cell responses was examined by using highly purified human peripheral blood B cells, as well as a variety of B lymphoblastoid cell lines and hybridomas. Following stimulation with the combination of a calcium ionophore and a phorbol ester, human B cells bound a soluble fusion protein containing the extracellular portion of CD40 and the Fc region of IgG1 (CD40.Ig). A variety of B cell lines and hybridomas also bound CD40.Ig, either constitutively or after activation. In addition, CD40.Ig specifically immunoprecipitated a 33-kDa glycoprotein from surface 125I-labeled activated B cells. The nucleotide sequence of the coding region of the CD40 ligand mRNA amplified by RT-PCR from activated T cells and B cell lines was identical. The CD40 ligand expressed on human B cells was important functionally because homotypic aggregation of CD40 ligand- expressing B cells was inhibited by the CD40.Ig construct. Additionally, RNA and DNA synthesis as well as Ig production by polyclonally activated, highly purified peripheral B cells and a variety of B cell lines were inhibited significantly by the CD40.Ig construct. Finally, B cell lines expressing the CD40 ligand induced Ig production from resting normal B cells in a CD40-dependent manner. These results indicate that human B cells express a ligand for CD40 that is identical with that expressed by activated T cells and that the B cell-expressed CD40 ligand plays an important role in facilitating responses of activated B cells.
This article has been cited by other articles:
![]() |
M. Dranitzki-Elhalel, J. H. Huang, M. Sasson, J. Rachmilewitz, M. Parnas, and M. L. Tykocinski CD40{middle dot}FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism Int. Immunol., April 1, 2007; 19(4): 355 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huggins, T. Pellegrin, R. E. Felgar, C. Wei, M. Brown, B. Zheng, E. C. B. Milner, S. H. Bernstein, I. Sanz, and M. S. Zand CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells Blood, February 15, 2007; 109(4): 1611 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Pham, A. T. Tamayo, L. C. Yoshimura, Y.-C. Lin-Lee, and R. J. Ford Constitutive NF-{kappa}B and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival Blood, December 1, 2005; 106(12): 3940 - 3947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Chen, H.-W. Chang, C.-J. Wu, C.-H. Yang, W. C. Hung, K.-H. Yeh, and M. Fu Percutaneous Transluminal Mitral Valvuloplasty Reduces Circulating Soluble CD40 Ligand in Rheumatic Mitral Stenosis Chest, July 1, 2005; 128(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Henderson, R. Ruhl, P. Lewis, M. Bentley, J. A. Nelson, and A. V. Moses Human Immunodeficiency Virus (HIV) Type 1 Vpu Induces the Expression of CD40 in Endothelial Cells and Regulates HIV-Induced Adhesion of B-Lymphoma Cells J. Virol., May 1, 2004; 78(9): 4408 - 4420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Citores, I Rua-Figueroa, C Rodriguez-Gallego, A Durantez, M I Garcia-Laorden, C Rodriguez-Lozano, J C Rodriguez-Perez, J A Vargas, and P Perez-Aciego The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus Ann Rheum Dis, March 1, 2004; 63(3): 310 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kaufman, P. J. Sime, and R. P. Phipps Expression of CD154 (CD40 Ligand) by Human Lung Fibroblasts: Differential Regulation by IFN-{gamma} and IL-13, and Implications for Fibrosis J. Immunol., February 1, 2004; 172(3): 1862 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Lee, J. Moyron-Quiroz, J. Rangel-Moreno, K. L. Kusser, L. Hartson, F. Sprague, F. E. Lund, and T. D. Randall CD40, but Not CD154, Expression on B Cells Is Necessary for Optimal Primary B Cell Responses J. Immunol., December 1, 2003; 171(11): 5707 - 5717. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-I. Imadome, M. Shirakata, N. Shimizu, S. Nonoyama, and Y. Yamanashi CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation PNAS, June 24, 2003; 100(13): 7836 - 7840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Challa, A. G. Eliopoulos, M. J. Holder, A. S. Burguete, J. D. Pound, A. Chamba, G. Grafton, R. J. Armitage, C. D. Gregory, H. Martinez-Valdez, et al. Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells Blood, May 1, 2002; 99(9): 3411 - 3418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez-Barnetche, V. Madrid-Marina, R. A. Flavell, and J. Moreno Does CD40 Ligation Induce B Cell Negative Selection? J. Immunol., February 1, 2002; 168(3): 1042 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Luft, M. Jefford, P. Luetjens, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky IL-1{beta} Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation J. Immunol., January 15, 2002; 168(2): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Blanca, E. W. Bere, H. A. Young, and J. R. Ortaldo Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5+ B Cells J. Immunol., December 1, 2001; 167(11): 6132 - 6139. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Leiva, B. Butler, J. Hempe, A. P. Ortigas, and R. U. Sorensen Up-Regulation of CD40 Ligand and Induction of a Th2 Response in Children Immunized with Pneumococcal Polysaccharide Vaccines Clin. Vaccine Immunol., March 1, 2001; 8(2): 233 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Strand Monoclonal antibodies and other biologic therapies Lupus, March 1, 2001; 10(3): 216 - 221. [Abstract] [PDF] |
||||
![]() |
H.-P. Brezinschek, T. Dorner, N. L. Monson, R. I. Brezinschek, and P. E. Lipsky The influence of CD40-CD154 interactions on the expressed human VH repertoire: analysis of VH genes expressed by individual B cells of a patient with X-linked hyper-IgM syndrome Int. Immunol., June 1, 2000; 12(6): 767 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szomolanyi-Tsuda, J. D. Brien, J. E. Dorgan, R. M. Welsh, and R. L. Garcea The Role of CD40-CD154 Interaction in Antiviral T Cell-Independent IgG Responses J. Immunol., June 1, 2000; 164(11): 5877 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S Dean, J. Tyrrell-Price, E. Crawley, and D. A Isenberg Cytokines and systemic lupus erythematosus Ann Rheum Dis, April 1, 2000; 59(4): 243 - 251. [Full Text] |
||||
![]() |
C. G. de Vinuesa, M. C. Cook, J. Ball, M. Drew, Y. Sunners, M. Cascalho, M. Wabl, G. G.B. Klaus, and I. C.M. MacLennan Germinal Centers without T Cells J. Exp. Med., February 7, 2000; 191(3): 485 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knorr, C. Amrehn, H. Seeberger, A. Rosenwald, S. Stilgenbauer, G. Ott, H.-K. Muller Hermelink, and A. Greiner Expression of Costimulatory Molecules in Low-Grade Mucosa-Associated Lymphoid Tissue-Type Lymphomas in Vivo Am. J. Pathol., December 1, 1999; 155(6): 2019 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Grammer, R. D. McFarland, J. Heaney, B. F. Darnell, and P. E. Lipsky Expression, Regulation, and Function of B Cell-Expressed CD154 in Germinal Centers J. Immunol., October 15, 1999; 163(8): 4150 - 4159. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kyburz, M. Corr, D. C. Brinson, A. Von Damm, H. Tighe, and D. A. Carson Human Rheumatoid Factor Production Is Dependent on CD40 Signaling and Autoantigen J. Immunol., September 15, 1999; 163(6): 3116 - 3122. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and E. Y. Denkers Protective Role for Interleukin-5 during Chronic Toxoplasma gondii Infection Infect. Immun., September 1, 1999; 67(9): 4383 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N. O. Solum, K. Forfang, S. S. Froland, and L. Gullestad Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes Circulation, August 10, 1999; 100(6): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Wu, Q. Vos, Y. Shen, A. Lees, S. R. Wilson, D. E. Briles, W. C. Gause, J. J. Mond, and C. M. Snapper In Vivo Polysaccharide-Specific IgG Isotype Responses to Intact Streptococcus pneumoniae Are T Cell Dependent and Require CD40- and B7-Ligand Interactions J. Immunol., July 15, 1999; 163(2): 659 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dubois, C. Barthelemy, I. Durand, Y.-J. Liu, C. Caux, and F. Briere Toward a Role of Dendritic Cells in the Germinal Center Reaction: Triggering of B Cell Proliferation and Isotype Switching J. Immunol., March 15, 1999; 162(6): 3428 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pound, A. Challa, M. J. Holder, R. J. Armitage, S. K. Dower, W. C. Fanslow, H. Kikutani, S. Paulie, C. D. Gregory, and J. Gordon Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells Int. Immunol., January 1, 1999; 11(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoshino, R. T. Winkler-Pickett, A. T. Mason, J. R. Ortaldo, and H. A. Young IL-13 Production by NK Cells: IL-13-Producing NK and T Cells Are Present In Vivo in the Absence of IFN-{gamma} J. Immunol., January 1, 1999; 162(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Datta Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells Lupus, November 1, 1998; 7(9): 591 - 596. [Abstract] [PDF] |
||||
![]() |
A. C. Grammer, J. L. Swantek, R. D. McFarland, Y. Miura, T. Geppert, and P. E. Lipsky TNF Receptor-Associated Factor-3 Signaling Mediates Activation of p38 and Jun N-Terminal Kinase, Cytokine Secretion, and Ig Production Following Ligation of CD40 on Human B Cells J. Immunol., August 1, 1998; 161(3): 1183 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Schattner, J. Mascarenhas, I. Reyfman, M. Koshy, C. Woo, S. M. Friedman, and M. K. Crow Chronic Lymphocytic Leukemia B Cells Can Express CD40 Ligand and Demonstrate T-Cell Type Costimulatory Capacity Blood, April 15, 1998; 91(8): 2689 - 2697. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moses, J. Nelson, and G. C. Bagby Jr The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis Blood, March 1, 1998; 91(5): 1479 - 1495. [Full Text] [PDF] |
||||
![]() |
E. S. Sobel, V. N. Kakkanaiah, J. Schiffenbauer, E. A. Reap, P. L. Cohen, and R. A. Eisenberg Novel Immunoregulatory B Cell Pathways Revealed by lpr-+ Mixed Chimeras J. Immunol., February 1, 1998; 160(3): 1497 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Ford, C. H. Yin, B. Barnhart, K. Sztam, and L. R. Covey CD40 Ligand Exerts Differential Effects on the Expression of I{gamma} Transcripts in Subclones of an IgM+ Human B Cell Lymphoma Line J. Immunol., January 15, 1998; 160(2): 595 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A New Mechanism of NK Cell Cytotoxicity Activation: The CD40-CD40 Ligand Interaction J. Exp. Med., June 16, 1997; 185(12): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Kwon, K. B. Tan, J. Ni, K. K. Kim, Y.-J. Kim, S. Wang, R. Gentz, G.-L. Yu, J. Harrop, S. D. Lyn, et al. A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation J. Biol. Chem., May 30, 1997; 272(22): 14272 - 14276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pound and J. Gordon Maintenance of Human Germinal Center B Cells In Vitro Blood, February 1, 1997; 89(3): 919 - 928. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |